Glyset

— THERAPEUTIC CATEGORIES —
  • Diabetes

Glyset Generic Name & Formulations

General Description

Miglitol 25mg, 50mg, 100mg; tabs.

Pharmacological Class

Alpha-glucosidase inhibitor.

How Supplied

Tabs—100

Manufacturer

Generic Availability

NO

Glyset Indications

Indications

Adjunct to diet in type 2 diabetes, alone or with a sulfonylurea.

Glyset Dosage and Administration

Adult

Take with the first bite of each main meal. Initially 25mg three times daily; may start at 25mg once daily (to minimize GI effects) and gradually increase to 25mg three times daily. Increase to 50mg three times daily after 4–8 weeks; usual max 100mg three times daily.

Children

Not established.

Glyset Contraindications

Contraindications

Ketoacidosis. Inflammatory bowel disease. Colonic ulceration. Partial intestinal obstruction or predisposition thereof. Chronic intestinal diseases associated with marked disorders of digestion or absorption. Conditions that may deteriorate from increased intestinal gas formation.

Glyset Boxed Warnings

Not Applicable

Glyset Warnings/Precautions

Warnings/Precautions

Significant renal dysfunction (serum creatinine >2mg/dL): not recommended. Use glucose, not sucrose, to treat hypoglycemia. Stress. Monitor 1-hour postprandial blood glucose initially and during titration then glycosylated hemoglobin. Pregnancy (Cat.B): consider using insulin instead. Nursing mothers: not recommended.

Glyset Pharmacokinetics

See Literature

Glyset Interactions

Interactions

Antagonized by intestinal adsorbents (eg, charcoal), pancreatin, amylase, other carbohydrate-splitting enzymes. May decrease levels of ranitidine, propranolol. Risk of hypoglycemia with concomitant sulfonylureas or insulin; consider reducing dose of these.

Glyset Adverse Reactions

Adverse Reactions

Transient flatulence, diarrhea, abdominal pain; low serum iron.

Glyset Clinical Trials

See Literature

Glyset Note

Not Applicable

Glyset Patient Counseling

See Literature